Investigating potential targets of Wulingsan in diabetic nephropathy through network pharmacology and experimental validation
BackgroundDiabetic Nephropathy (DN), a major microvascular complication of diabetes, poses challenges for current treatments to effectively delay its progression. Wulingsan (WLS), a traditional Chinese medicine formula, possesses potential for regulating water-fluid metabolism, and exhibits anti-inf...
Saved in:
Main Authors: | Xicheng Hu, Zhen Wang, Liyan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2025.1647796/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Huangkui capsule combined with finerenone attenuates diabetic nephropathy by regulating the JAK2/STAT3 signaling pathway based on network pharmacology, molecular docking, and experimental verification
by: Xuanke Liu, et al.
Published: (2025-08-01) -
Network pharmacological investigation and experimental verification of the peel of Zea mays L. regulating metabolic reprogramming in the treatment of diabetic nephropathy
by: Andong Wang, et al.
Published: (2025-07-01) -
Integrating network pharmacology and transcriptomics to identify solasonine’s anti-osteosarcoma targets and experimental validation
by: Daihao Wei, et al.
Published: (2025-08-01) -
Mitochondrial insights: key biomarkers and potential treatments for diabetic nephropathy and sarcopenia
by: Yi Wei Chen, et al.
Published: (2025-07-01) -
Revealing the Multi-Target Mechanisms of Fespixon Cream in Diabetic Foot Ulcer Healing: Integrated Network Pharmacology, Molecular Docking, and Clinical RT-qPCR Validation
by: Tianbo Li, et al.
Published: (2025-06-01)